AtriCure Stock

AtriCure EBITDA per Employee

The EBITDA per Employee of AtriCure (ATRC) as of Aug 7, 2026 is -4,721.92 USD. In the previous year, EBITDA per Employee was -52,989.04 USD — a change of -91.09% (higher).

EBITDA per Employee

-4,721.92USD

YoY

-91.09%

Last updated:

EBITDA per Employee of AtriCure is 2026 -4,721.92 USD. EBITDA per Employee of AtriCure was 2025 -52,989.04 USD. It decreases by -91.09% higher compared to the previous year.
Access this data via the Eulerpool API

AtriCure Stock analysis

What does AtriCure do? AtriCure Inc is a medical technology company that specializes in the development of innovative products and therapies for the treatment of cardiac arrhythmias. It was founded in 2000 and is headquartered in Mason, Ohio, USA. The company offers a wide range of products and therapies, including the isolation of pulmonary veins, catheter technology, radiofrequency ablation, and innovative solutions for the treatment of heart valve diseases and other structural heart problems. AtriCure is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AtriCure stock

EBITDA per Employee of AtriCure is -4,721.92 USD in 2026.

EBITDA per Employee of AtriCure changed from -52,989.04 USD to -4,721.92 USD, representing a -91.09% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee AtriCure since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's AtriCure historically and in real time.

Access this data via the Eulerpool API

Workforce — AtriCure

All Key Metrics — AtriCure